TARRYTOWN, N.Y., Dec. 22, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017. The presentation is scheduled for 3:30 p.m. Pacific Time (6:30 p.m. Eastern Time) and may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page. A breakout session will immediately follow the formal presentation and can also be accessed at www.regeneron.com. An archived version of the presentation and the breakout session will be available for 30 days.
About Regeneron Pharmaceuticals, Inc.
Regeneron (NASDAQ: REGN) is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL cholesterol and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, atopic dermatitis, asthma, pain, cancer and infectious diseases. For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/regeneron-announces-presentation-at-the-35th-annual-jp-morgan-healthcare-conference-300382426.html
SOURCE Regeneron Pharmaceuticals, Inc.